The Use of Novel Non-Vitamin K Antagonist Oral Anticoagulants Following Closure of the Left Atrial Appendage: Preliminary Results of Clinical Follow-Up-Reference-Cited by-同舟云学术

The Use of Novel Non-Vitamin K Antagonist Oral Anticoagulants Following Closure of the Left Atrial Appendage: Preliminary Results of Clinical Follow-Up

Published:2021-03 Issue: Volume:Volume 15 Page:1067-1073
ISSN:1177-8881
Container-title:Drug Design, Development and Therapy
language:en
Short-container-title:DDDT

Author:

Zhu Jing,Xu Jian^ORCID

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmaceutical Science,Pharmacology

Reference26 articles.

1. 2016 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration With EACTS

2. First results of the Brazilian Registry of Percutaneous Left Atrial Appendage Closure

3. Early Canadian Multicenter Experience With WATCHMAN for Percutaneous Left Atrial Appendage Closure

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Twice-daily rivaroxaban after percutaneous left atrial appendage closure for atrial fibrillation;Frontiers in Pharmacology;2024-02-22

2. Effectiveness and safety of short-term anticoagulant regimens after left atrial appendage occlusion: A systematic review and meta-analysis;Thrombosis Research;2024-01

3. Short-term antithrombotic strategies after left atrial appendage occlusion: a systematic review and network meta-analysis;Frontiers in Pharmacology;2023-09-01

4. Direct Oral Anticoagulant Versus Warfarin After Left Atrial Appendage Closure With WATCHMAN: Updated Systematic Review and Meta-analysis;Current Problems in Cardiology;2022-11

5. Comparison of outcomes between novel oral anticoagulants and warfarin monotherapy in patients with left atrial appendage closure: A systematic review and meta-analysis;Frontiers in Cardiovascular Medicine;2022-10-24